Page 66 - GALENIKA MEDICAL JOURNAL
P. 66

Abstract

          MELAS (Mitochondrial Encephalopathy Lactic Acidosis and Stroke-like episodes) syndrome is a condition characterized by
          mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes. It is a rare, inherited, neurodegenerative disorder
          caused by mitochondrial dysfunction that leads to energy production disturbances. The disease most commonly begins
          at a younger age, before the age of 40, with episodes resembling strokes, and psychiatric symptoms can also occur in
          the early stages of the disease. Later on, encephalopathy may develop, which is accompanied by epileptic seizures and/
          or dementia. Psychiatric disorders in MELAS syndrome are present but insufficiently studied, which should be considered
          during diagnosis to prevent th disease from going unrecognized. Early diagnosis of any disease, including MELAS, is crucial
          as timely initiation of treatment significantly contributes to a more favorable course and better prognosis of the disease.
          When diagnosing MELAS, attention should be paid to the potential presence of psychiatric disorders.


          Keywords: MELAS, genetics, diagnosis, psychiatric disorders






          Literatura                                         15.  Bianchi MC, Sgandurra G, Tosetti M, Battini R, Cioni G. Brain
                                                                magnetic resonance in the diagnostic evaluation of mitochondrial
                                                                encephalopathies. Biosci Rep. 2007 Jun;27(1-3):69-85.
          1.  Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP.   16.  Kaufmann P, Shungu DC, Sano MC, Jhung S, Engelstad K, Mitsis E, et
             Mitochondrial myopathy, encephalopathy, lactic acidosis, and   al. Cerebral lactic acidosis correlates with neurological impairment in
             strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984   MELAS. Neurology. 2004 Apr 27;62(8):1297-302.
             Oct;16(4):481-8.
                                                             17.  DiMauro S, Hirano M. Mitochondrial encephalomyopathies: an update.
          2.  van den Ouweland JM, Lemkes HH, Ruitenbeek W, Sandkuijl LA, de   Neuromuscul Disord. 2005 Apr;15(4):276-86.
             Vijlder MF, Struyvenberg PA, et al. Mutation in mitochondrial tRNA(Leu)
             (UUR) gene in a large pedigree with maternally transmitted type II   18.  Lačković M. Psihijatrijski poremećaji kod bolesnika sa naslednim
             diabetes mellitus and deafness. Nat Genet. 1992 Aug;1(5):368-71.   bolestima malih krvnih sudova mozga. Magistraska teza, Medicinski
          3.  Moraes CT, Ciacci F, Silvestri G, Shanske S, Sciacco M, Hirano M, et al.   fakultet Univerziteta u Beogradu, Beograd, 2010.
             Atypical clinical presentations associated with the MELAS mutation at   19.  Lačković M, Damjanović A, Ivković M, Dunjić-Kostić B, Pantović-
             position 3243 of human mitochondrial DNA. Neuromuscul Disord. 1993   Stefanović M. MELAS – psihijatrijski aspekti. Engrami, 2015; 37(3): 5−15.
             Jan;3(1):43-50.
                                                             20.  Lačković M, Bajčetić M, Rovčanin B. Nasledne bolesti malih krvnih
          4.  Deschauer M, Wieser T, Neudecker S, Lindner A, Zierz S. Mitochondrial   sudova mozga. U: Vesna Lačković i sar., Histologija i embriologija
             3243 A-->G mutation (MELAS mutation) associated with painful muscle   kardiovaskularnog i limfnog vaskularnog sistema - klinički značaj
             stiffness. Neuromuscul Disord. 1999 Jul;9(5):305-7.   (Kanjuh V, Todorović V, urednici). Crnogorska akademija nauka i
                                                                umjetnosti, Klinički centar Crne Gore, Podgorica 2020, str. 307-14.
          5.  Sue CM, Bruno C, Andreu AL, Cargan A, Mendell JR, Tsao CY, et al.
             Infantile encephalopathy associated with the MELAS A3243G mutation.   21.  Bajčetić M. Značaj ultrastrukturalnih istraživanja dermisa, mišića i
             J Pediatr. 1999 Jun;134(6):696-700.                suralnog nerva u diferencijalnoj dijagnozi bolesti malih i srednjih krvnih
          6.  Hasegawa H, Matsuoka T, Goto Y, Nonaka I. Strongly succinate   sudova nervnog sistema. Doktorska disetacija, Medicinski fakultet
                                                                Univerziteta u Beogradu, Beograd, 2010.
             dehydrogenase-reactive blood vessels in muscles from patients with
             mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-  22.  Kostic J, Bajcetic M, Lackovic M, Zaletel I, Lackovic V.
             like episodes. Ann Neurol. 1991 Jun;29(6):601-5.   Ultrastructural changes of skeletal muscle fibers in Mitochondrial
                                                                Encephalomyopathies. Microscopy Confrerence MC 2013, Regensburg,
          7.  Gilchrist JM, Sikirica M, Stopa E, Shanske S. Adult-onset MELAS. Evidence   August 25–30.
             for involvement of neurons as well as cerebral vasculature in strokelike
             episodes. Stroke. 1996 Aug;27(8):1420-3.        23.  Ciafaloni E, Ricci E, Shanske S, Moraes CT, Silvestri G, Hirano M, et al.
                                                                MELAS: clinical features, biochemistry, and molecular genetics. Ann
          8.  Betts J, Jaros E, Perry RH, Schaefer AM, Taylor RW, Abdel-All Z, et al.   Neurol. 1992 Apr;31(4):391-8.
             Molecular neuropathology of MELAS: level of heteroplasmy in individual
             neurones and evidence of extensive vascular involvement. Neuropathol   24.  Shanske S, Pancrudo J, Kaufmann P, Engelstad K, Jhung S, Lu J, et al.
             Appl Neurobiol. 2006 Aug;32(4):359-73.             Varying loads of the mitochondrial DNA A3243G mutation in different
          9.  Iizuka T, Sakai F, Ide T, Miyakawa S, Sato M, Yoshii S. Regional cerebral   tissues: implications for diagnosis. Am J Med Genet A. 2004 Oct
                                                                1;130A(2):134-7.
             blood flow and cerebrovascular reactivity during chronic stage of
             stroke-like episodes in MELAS -- implication of neurovascular cellular   25.  Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR)
             mechanism. J Neurol Sci. 2007 Jun 15;257(1-2):126-38.  gene associated with the MELAS subgroup of mitochondrial
                                                                encephalomyopathies. Nature. 1990 Dec 13;348(6302):651-3.
          10.  Hirano M, Ricci E, Koenigsberger MR, Defendini R, Pavlakis SG, DeVivo
             DC, et al. Melas: an original case and clinical criteria for diagnosis.   26.  Onishi H, Kawanishi C, Iwasawa T, Osaka H, Hanihara T, Inoue K, et
             Neuromuscul Disord. 1992;2(2):125-35.              al. Depressive disorder due to mitochondrial transfer RNALeu(UUR)
                                                                mutation. Biol Psychiatry. 1997 Jun 1;41(11):1137-9.
          11.  Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic
             acidosis, and strokelike episodes (MELAS): current concepts. J Child   27.  Miyaoka H, Suzuki Y, Taniyama M, Miyaoka Y, Shishikura K, Kamijima K,
             Neurol. 1994 Jan;9(1):4-13.                        et al. Mental disorders in diabetic patients with mitochondrial transfer
          12.  Chinnery PF, Turnbull DM. Epidemiology and treatment of   RNA(Leu) (UUR) mutation at position 3243. Biol Psychiatry. 1997 Sep
                                                                15;42(6):524-6.
             mitochondrial disorders. Am J Med Genet. 2001 Spring;106(1):94-101.
                                                             28.  Jaksch M, Lochmuller H, Schmitt F, Volpel B, Obermaier-Kusser B,
          13.  Kartsounis LD, Troung DD, Morgan-Hughes JA, Harding AE. The   Horvath R. A mutation in mt tRNALeu(UUR) causing a neuropsychiatric
             neuropsychological features of mitochondrial myopathies and   syndrome with depression and cataract. Neurology. 2001 Nov
             encephalomyopathies. Arch Neurol. 1992 Feb;49(2):158-60.   27;57(10):1930-1.
          14.  Lang CJ, Brenner P, Heub D, Engelhardt A, Reichmann H, Seibel P, et al.   29.  Gardner A, Boles RG. Is a “mitochondrial psychiatry” in the future? A
             Neuropsychological status of mitochondrial encephalomyopathies. Eur   review. Curr Psychiat Reviews 2005; 1: 255–71.
             J Neurol. 1995 Jul;2(3):171-6.

          64     DOI: 10.5937/Galmed2307062L
   61   62   63   64   65   66   67   68   69   70   71